Cutaneous manifestations of infective endocarditis

Authors

  • Victoria Catalina Mardon General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
  • Bárbara Alonso General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
  • María Inés Hernández General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
  • Florencia Quadrana General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
  • Alejandra Abeldaño General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Keywords:

infective endocarditis, Osler's nodes, Janeway lesions

Abstract

Infective endocarditis is a pathology with low incidence and high morbidity, so the early diagnosis and timely treatment are essential. Clinical presentation is varied; cutaneous manifestations include purpura, subungual hemorrhages, Osler’s nodes, and Janeway lesions. We report a case with skin´s lesions typical of IE caused by Staphylococcus aureus in a patient with systemic lupus erythematosus. The importance of the dermatological examination as a diagnostic element of this pathology is highlighted.

Author Biographies

  • Victoria Catalina Mardon, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

    Second Year Concurrent. Dermatology Unit

  • Bárbara Alonso, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

    Dermatologist Physician. Dermatology Unit

  • María Inés Hernández, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

    Plant Doctor. Dermatology Unit

  • Florencia Quadrana, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

    Chief of Residents. Dermatology Unit

  • Alejandra Abeldaño, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

    Head of the Dermatology Unit. Dermatology Unit

References

I. Casabe JH. Endocarditis infecciosa: una enfermedad cambiante. Medicina 2008;68:164-174.

II. Casabe JH, Giunta G, Varini S, Brisani JL, et ál. Consenso de endocarditis infecciosa. Rev Argent Cardiol 2016;84:1-49.

III. Avellana PM, García Aurelio M, Swieszkowski S, Nacinovich F, et ál. Endocarditis infecciosa en la República Argentina. Resultados del estudio EIRA 3. Rev Argent Cardiol 2018;86:20-28.

IV. Servy A, Valeyrie-Allanore L, Alla, F, Lechiche C, et ál. Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol 2014;150:494–500.

V. Miller CS, Egan RM, Falace DA, Rayens MK, et ál. Prevalence of infective endocarditis in patients with systemic lupus erythematosus. J Am Dent Assoc 1999;130(3):387-392.

VI. Alpert JS, Krous HF, Dalen JE, O'Rourke RA, et ál. Pathogenesis of Osler's nodes. Ann InternMed 1976;85:471-473.

VII. Farrior JB, Silverman ME. A consideration of the differences between a Janeway's lesion and an Osler's node in infectious endocarditis. Chest1976;70:239-243.

VIII. Kerr A, Tan J. Biopsies of the Janeway lesion of infective endocarditis. J Cutan Pathol 1979;6:124-129.

IX. Yee J, McAllister K. The utility of Osler's nodes in the diagnosis of infective endocarditis. Chest1987;92:751-752.

X. Li JS, Sexton DJ, Mick N, Nettles R, et ál. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638.

Downloads

Published

2019-09-20

Issue

Section

Clinical Cases